Treatment Pathway
Treatment of Gallstones
Gallstones are hardened deposits of digestive fluid that form in the gallbladder. They can range from sand-grain size to golf-ball size. Many are asymptomatic, but when they block a duct they cause severe 'biliary colic' pain in the upper right abdomen.
ACG (American College of Gastroenterology)BSG (British Society of Gastroenterology)ESGEAASLD (liver)ECCO (IBD)Maastricht Consensus (H. pylori)NICE
Managing Gallstones effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Gallstones can maintain a good quality of life and prevent serious complications.
First-Line Treatment Principles
- ✓PPI as cornerstone for acid-related disorders (GERD, peptic ulcer, H. pylori eradication regimens)
- ✓H. pylori eradication: PPI + clarithromycin + amoxicillin (7–14 days); bismuth quadruple if resistance suspected
- ✓IBD: 5-ASA for mild UC; corticosteroids for induction; biologics (anti-TNF, anti-integrin) for moderate-severe
- ✓Hepatitis B/C: antiviral therapy (tenofovir/entecavir for HBV; DAAs for HCV with >95% SVR rate)
- ✓Cirrhosis: treat underlying cause + complications (ascites, varices, HE) systematically
What to Do Now
- Learn your personal risk factors for Gallstones (family history, age, lifestyle)
- Attend regular health check-ups and screening tests appropriate for your age and risk
- Track new or changing symptoms, especially those associated with Gallstones
- Use our AI symptom checker to assess whether your symptoms fit an early Gallstones pattern
- Discuss preventive strategies and early monitoring with your GP
- Build a personalised management plan with your GP or specialist
- Adhere consistently to prescribed medications — do not stop without medical advice
- Adopt a Gallstones-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)
Non-Pharmacological Management
- •Dietary modification: low-FODMAP for IBS; gluten-free diet for coeliac disease; low-fat for pancreatitis
- •Alcohol cessation: critical in alcoholic liver disease, pancreatitis, GERD
- •Weight loss: reduces GERD symptoms and improves NAFLD (5–10% weight loss reduces hepatic steatosis)
- •Elevate bed head; avoid late meals; avoid trigger foods in GERD
- •Regular meals; avoid NSAIDs and aspirin (gastric mucosal damage); no smoking
- •Endoscopic surveillance: Barrett's oesophagus, IBD colon cancer screening, cirrhosis for HCC
- •Vaccination: hepatitis A and B for unvaccinated at-risk patients
Treatment Goals
🎯Symptom remission and maintained quality of life in IBD/IBS/GERD
🎯Mucosal healing in IBD (endoscopic remission)
🎯H. pylori eradication confirmed
🎯Prevention of cirrhosis complications: hepatic decompensation, variceal bleeding, HCC
🎯Sustained virological response (SVR) in hepatitis C
Monitoring Parameters
- ◆LFTs, bilirubin, albumin, INR: liver function — monthly in acute liver disease, every 3–6 months in chronic
- ◆FBC: anaemia (GI bleeding, malabsorption), leucopenia (azathioprine toxicity)
- ◆Faecal calprotectin: non-invasive IBD disease activity monitoring
- ◆Colonoscopy: IBD dysplasia surveillance every 1–5 years depending on duration and extent
- ◆H. pylori test of cure: UBT or stool antigen 4 weeks after eradication therapy
- ◆Hepatic elastography (FibroScan): assess fibrosis progression in chronic liver disease
- ◆Alpha-fetoprotein + ultrasound: HCC surveillance in cirrhosis every 6 months
Red Flags — When to Escalate
- ⚠Any of the characteristic symptoms of Gallstones — even mild — in a high-risk individual
- ⚠Progressive worsening of early warning signs over weeks
- ⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
- ⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
- ⚠Strong family history of Gallstones combined with new relevant symptoms
- ⚠Sudden worsening of Gallstones symptoms despite established treatment
Escalation Criteria
- →Acute GI bleeding: upper GI endoscopy within 24h; resuscitation, IV PPI, haemostatic therapy
- →Acute severe UC (Truelove-Witts criteria) → hospitalisation, IV steroids; escalate to biologics/surgery if no response at 72h
- →Hepatic encephalopathy: lactulose, rifaximin; identify precipitant; assess for transplant listing
- →Acute-on-chronic liver failure: specialist gastroenterology/transplant centre referral
Special Populations
Pregnancy: many IBD biologics continue through pregnancy (anti-TNF switch to certolizumab if needed); avoid methotrexate
Elderly: NSAIDs major GI risk — prescribe PPI; vigilance for GI bleeding on anticoagulants
Paediatric IBD: growth and development monitoring; early biological therapy consideration
Immunocompromised: lower threshold for investigation; atypical pathogens (CMV colitis, Cryptosporidium)
Clinical Insights
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →